Life Sciences Debate: STAT readers are weighing the science behind “blue zones,” with discussion also spilling into open-access publishing fees and broader questions about how research claims are tested and communicated. Science Publishing & Access: The debate highlights a tension between scrutiny and what gets left out when high-profile health longevity stories are challenged—an issue that matters for how readers interpret studies and for how journals structure access. Book Review: A new review spotlights Yusuf Olanrewaju Sagaya’s 2026 autobiography, “Yusuf Olanrewaju Sagaya: Recollection of My Story,” praised for its engineering-rooted life perspective and the reviewer’s long personal connection to the author.